For Siwen Hu-Lieskovan, MD, PhD, it was the promise of immunotherapy—that is, harnessing the body’s own immune system to fight cancer—that inspired her to get into cancer research. Training under one of the pioneers of immunotherapy, she witnessed amazing survival stories of patients. The project Hu-Lieskovan proposed for the 5 For The Fight grant is to tackle the immune-related adverse events when adding different immunotherapies.... Read More
Dr. Hu-Lieskovan’s laboratory uses cutting-edge technologies to investigate mechanisms of resistance to immunotherapy, develop novel combination strategies to overcome resistance, improve efficacy, and monitor and prevent immunotherapy-induced toxicities. Her team conducts clinical trials to bring the discovery from her laboratory to the clinic and to improve the effectiveness and tolerability of immunotherapy, with the ultimate goal of bringing the survival benefit of immunotherapy to every patient.
News & Blog
Huntsman Cancer Institute Researcher Receives National Cancer Clinical Investigator Team Leadership Award
Siwen Hu-Lieskovan, PhD, MD, physician scientist at Huntsman Cancer Institute and assistant professor of medicine at the University of Utah, has received the National Cancer Institute 2020 Cancer Clinical Investigator Team Leadership Award. The award recognizes outstanding clinical investigators at NCI-designated Cancer Centers who participate extensively in NCI-funded clinical trials, and whose leadership and activities promote a successful culture of collaborative clinical research. ... Read More
5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research Fellowship in partnership with Huntsman Cancer Institute at the University of Utah. ... Read More
At Huntsman Cancer Institute, we're committed to delivering a cancer-free frontier. Our cancer researchers are on the cutting-edge of discovery and innovation, and we're excited by what these advancements mean for melanoma prevention and treatment. Together, we're building the future we want.... Read More
Only a few months after she retired in October 2018, Lynn Walker knew something was wrong with her health. Without any prior history of skin cancers, she learned that she had an advanced form of melanoma that has spread all over her body. Walker worried about the possibility of going through chemotherapy and not surviving the effects of cancer treatment, let alone melanoma. But she soon learned of another approach that held promise for her type of cancer: immunotherapy.... Read More